Application 070967
- Type
- ANDA
- Sponsor
- FRESENIUS KABI USA
Application Products
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|
| 001 | SENSORCAINE | BUPIVACAINE HYDROCHLORIDE; EPINEPHRINE BITARTRATE | INJECTABLE;INJECTION | 0.25%;0.0091MG/ML | No | No |
NDC Listings For This Application
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|
| 51662-1397 | SENSORCAINE(R) (BUPIVACAINE HCI AND EPINEPHRINE) | SENSORCAINE(R) (BUPIVACAINE HCI AND EPINEPHRINE) | HF Acquisition Co LLC, DBA HealthFirst | ANDA | Current |
| 51662-1397 | SENSORCAINE(R) (BUPIVACAINE HCI AND EPINEPHRINE) | SENSORCAINE(R) (BUPIVACAINE HCI AND EPINEPHRINE) | HF Acquisition Co LLC, DBA HealthFirst | ANDA | Current |
| 51662-1397 | SENSORCAINE(R) (BUPIVACAINE HCI AND EPINEPHRINE) | SENSORCAINE(R) (BUPIVACAINE HCI AND EPINEPHRINE) | HF Acquisition Co LLC, DBA HealthFirst | ANDA | Current |
| 63323-461 | SENSORCAINE | BUPIVACAINE HYDROCHLORIDE and EPINEPHRINE BITARTRATE | Fresenius Kabi USA, LLC | ANDA | Current |
| 63323-461 | SENSORCAINE | BUPIVACAINE HYDROCHLORIDE and EPINEPHRINE BITARTRATE | Fresenius Kabi USA, LLC | ANDA | Current |